Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.185 EUR | -0.91% | -3.32% | -16.60% |
Evolution of the average Target Price on Innate Pharma
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Innate Pharma
SVB Leerink |
EPS Revisions
- Stock Market
- Equities
- IPH Stock
- Consensus Innate Pharma